COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer
Abiraterone has become the first-choice treatment for men with metastatic prostate cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Robert J. Jones, MBChB, PhD Tags: Genitourinary Cancers Oncology Journal Prostate Cancer Source Type: news